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A B S T R A C T
Background: Epidemiologic and animal-based studies have raised concern over the potential impact of fluoride
exposure on neurobehavioral development as manifested by lower IQ and deficits in attention. To date, no
prospective epidemiologic studies have examined the effects of prenatal fluoride exposure on behavioral out-
comes using fluoride biomarkers and sensitive measures of attention.
Objective: We aimed to examine the association between prenatal fluoride exposure and symptoms associated
with attention-deficit/hyperactivity disorder (ADHD).
Method: 213 Mexican mother-children pairs of the Early Life Exposures to Environmental Toxicants (ELEMENT)
birth cohort study had available maternal urinary samples during pregnancy and child assessments of ADHD-like
behaviors at age 6–12. We measured urinary fluoride levels adjusted for creatinine (MUFcr) in spot urine samples
collected during pregnancy. The Conners' Rating Scales-Revised (CRS-R) was completed by mothers, and the
Conners' Continuous Performance Test (CPT-II) was administered to the children.
Results: Mean MUFcr was 0.85mg/L (SD=0.33) and the Interquartile Range (IQR) was 0.46mg/L. In multi-
variable adjusted models using gamma regression, a 0.5mg/L higher MUFcr (approximately one IQR higher)
corresponded with significantly higher scores on the CRS-R for DSM-IV Inattention (2.84 points, 95% CI: 0.84,
4.84) and DSM-IV ADHD Total Index (2.38 points, 95% CI: 0.42, 4.34), as well as the following symptom scales:
Cognitive Problems and Inattention (2.54 points, 95% CI: 0.44, 4.63) and ADHD Index (2.47 points; 95% CI:
0.43, 4.50). The shape of the associations suggested a possible celling effect of the exposure. No significant
associations were found with outcomes on the CPT-II or on symptom scales assessing hyperactivity.
Conclusion: Higher levels of fluoride exposure during pregnancy were associated with global measures of ADHD
and more symptoms of inattention as measured by the CRS-R in the offspring.
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1. Introduction
Fluoride, the ionized form of the halogen element fluorine, exists
widely in the environment and is the most electronegative and reactive
among all elements (ATSDR, 2010). Its well-known cariostatic effect led
to the addition of fluoride to water, salt, and milk in some countries.
Other sources of fluoride include dental products, such as toothpastes,
mouth rinses, and varnishes, supplements, processed foods made with
fluoridated water, fluoride-containing pesticides, teas, and fluorinated
pharmaceuticals. Systemic ingestion of fluoride through water and
water-based beverages is the main source of fluoride intake, accounting
for approximately 75% of dietary fluoride intake among adults living in
communities that fluoridate their water supply in the United States
(U.S. Environmental Protection Agency, 2010; USDA (U.S. Department
of Agriculture), 2005). However, in Mexico City, individuals are pri-
marily exposed to fluoride through fluoridated salt (mean concentra-
tion of fluoride in salt is 250 ± 50 ppm), and to varying degrees of
naturally-occurring fluoride in water, which have been reported to
range from 0.15 to 1.38mg/L (Juárez-López et al., 2007; Martinez-Mier
et al., 2005). Public water supplies are not fluoridated in Mexico and
the mean fluoride content of the water supply is not publicly available.
Long-term exposure to fluoride is regarded by the World Health
Organization as being beneficial, including both prevention of dental
caries and treating osteoporosis, though excess intake can also cause
potential health hazards, including dental and skeletal fluorosis.
Fluoride is also shown to readily cross the placenta (Shen and Taves,
1974) and accumulate in fetal brain tissues (Narayanaswamy and Piler,
2009), thereby inducing toxicity (Dong et al., 1993; Jiang et al., 2014).
Several animal (Chen et al., 2003; Mcpherson et al., 2018; Mullenix
et al., 1995) and human studies (Bashash et al., 2017; Choi et al., 2012)
have explored associations between early-life exposure to fluoride and
decrements in cognitive function and attention-related behaviors. An
ecologic study reported an association between state level prevalence of
community water fluoridation and prevalence of ADHD among youth
living in the United States (Malin and Till, 2015). Given the increased
vulnerability of the developing fetus to environmental exposures
(Lanphear, 2015), as well as the widespread distribution of fluoride in
society, the potential impact of prenatal exposure to fluoride warrants
further study.
Attention-deficit hyperactivity disorder (ADHD) is the most
common neurodevelopmental disorder in school-aged children and
adolescents, with a worldwide prevalence estimated at about 5%
(Polanczyk et al., 2007). Symptoms of ADHD include difficulties with
attention, impulsivity, and/or hyperactivity at a level that is severe
enough to be associated with impairments in academic and social
functioning (American Psychiatric et al., 2013). Although genetics have
been shown to play an important role in an individual's susceptibility to
ADHD, with estimates of heritability from twin studies in the range of
60–70% (Posthuma and Polderman, 2013), several environmental fac-
tors have also been implicated. Environmental risk factors for ADHD
include prenatal tobacco and alcohol exposure, heavy metal and che-
mical exposures, including lead (Huang et al., 2016), mercury, orga-
nochlorines, air pollution (Fuertes et al., 2016; Perera et al., 2018;
Sentís et al., 2017) and nutritional factors (Polańska et al., 2012).
The purpose of the current study was to prospectively assess the
relationship between prenatal exposure to fluoride and parent-reported
behaviors associated with ADHD among 6–12 year old children born to
mothers living in Mexico City. We tested whether fluoride exposure
associated with inattentive and/or hyperactive behaviors.
2. Methods
2.1. Study population
Participants included a subset of mother-child dyads enrolled in
various longitudinal birth cohort studies of the Early Life Exposure in
Mexico to Environmental Toxicants (ELEMENT) project (Aafeiche et al.,
2011; Bashash et al., 2017). We included mother-child pairs from two
of the four ELEMENT cohorts (cohorts 2A and 3) for which maternal
urinary samples during trimesters of pregnancy were available. Parti-
cipants in cohort 2A (Bashash et al., 2017) were recruited between
1997 and 1999 whereas participants in cohort 3 were recruited be-
tween 2001 and 2003. We included participants if they had at least one
archived urine sample from pregnancy, were ≤14weeks of gestation at
the time of recruitment, and their children underwent behavioral
testing between the ages of 6 and 12, as described elsewhere (Bashash
et al., 2017). Participants were excluded if they reported a history of
psychiatric disorder(s), if there were medical complications (i.e. high-
risk pregnancy, gestational diabetes, pre-eclampsia, renal disease, cir-
culatory diseases, hypertension, continuous use of prescription drugs,
or seizures during the index pregnancy), or if there was known ma-
ternal alcohol or illegal drug use during pregnancy. The study proce-
dures were approved by the Institutional Review Boards of the National
Institute of Public Health of Mexico, University of Michigan, Indiana
University, University of Toronto, and Harvard School of Public Health,
as well as participating clinics. Written informed consent was obtained
from all participating families prior to study evaluation.
2.2. Fluoride measurements
Concentration of fluoride measured in maternal urinary samples
was used as biomarker of prenatal fluoride exposure. Urine has been
described as a suitable biomarker for fluoride since it serves as the main
pathway through which fluoride is eliminated from the body and ex-
cretion is proportional to the total fluoride intake, but modified by
factors like diet and various systemic conditions, such as recent fluoride
exposure and urinary pH, as well as variation in creatinine excretion by
muscle mass, age, sex, and other factors (Barr et al., 2005; Aylward
et al., 2015). Ideally, overnight fasting or 24-hour urine samples are
considered to be the optimal dosimeter for measuring chronic fluoride
exposure in order to limit diurnal variations and the influence of diet
associated with spot samples (Petersen et al., 2014). Because 24-hour
urinary samples were not available in our sample, we used spot samples
that were corrected for urinary dilution using urinary creatinine, as
described elsewhere (Petersen et al., 2014). Each woman in the current
sample provided at least one spot (second morning void) urine sample
(Thomas et al., 2016) during pregnancy (range: 10 to 38weeks). We
then calculated the average of all available creatinine-adjusted ma-
ternal urinary fluoride (MUF) concentrations (Bashash et al., 2017).
Further information regarding participant recruitment, data collection
methods, as well as methods for fluoride sample shipping, storage, and
analysis can be found elsewhere (Bashash et al., 2017).
2.3. Attention outcomes
Behaviors associated with ADHD were assessed using the Spanish
version of the Conners' Rating Scales-Revised (CRS-R) (Conners, 1997),
which has been validated for the evaluation of ADHD (Ortiz-Luna and
Acle-Tomasini, 2006). The CRS-R contains three ADHD scales that
correspond with the Diagnostic and Statistical Manual of Mental Dis-
orders – 4th edition (DSM-IV) criteria for ADHD: 1) DSM-IV Inattention
Index, 2) DSM-IV Hyperactive-Impulsive Index, and 3) DSM-IV Total
Index (inattentive and hyperactive-impulsive behaviors combined). It
also examines seven types of behavior problems that were derived
through factor analysis, including: Oppositional, Anxious-Shy, Cogni-
tive Problem/Inattention, Hyperactivity, Perfectionism, Psychosomatic,
and Social Problems. In addition, the CRS-R contains four index scores
that were derived based on theory and prior research: Conners' ADHD
Index; Conners' Global Index (CGI): Restless-Impulsive; CGI: Emotional
Lability, and CGI. For the purpose of the current study, we examined
the three DSM-IV ADHD scales as our primary outcomes because these
scales are intended to screen for ADHD, and are commonly used to
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study the association between diverse environmental contaminants and
ADHD-behavior problems (Huang et al., 2016; Perera et al., 2018). We
also examined outcomes from two behavior scales (Cognitive Problem/
Inattention and Hyperactivity) and two index scores (Conners' ADHD
Index and CGI: Restless-Impulsive), as done in our prior work with lead
(Huang et al., 2016). The Conners' ADHD Index, in particular, has been
shown to exhibit favorable specificity and sensitivity in ADHD assess-
ment (Chang et al., 2016). In addition, we assessed sustained attention
and inhibitory control using the Conners' Continuous Performance Test
(CPT-II, 2nd Edition), a computer-administered signal detection para-
digm (Conners, 2000). Using the CPT-II, we measured errors of omis-
sion and commission, and hit reaction time (response latency). Mothers
completed the CRS-R at the same follow-up visits that the child com-
pleted the CPT-II. All measures were standardized for age- and sex.
Higher T-scores (mean of 50, SD of 10) indicate poorer performance. All
psychometric tests were applied under the supervision of an experi-
enced psychologist (LS).
2.4. Measurement of covariates
Covariate data were individually obtained throughout the duration
of the study. During the first pregnancy visit, questionnaires were used
to collect information concerning maternal age, maternal education,
history of smoking, and marital status. At delivery, information re-
garding birth weight, child sex, birth order, and gestational age (cal-
culated by nurses) was obtained. Mothers also responded to a socio-
economic status questionnaire (Bashash et al., 2017) during the visit
when the psychometric tests were administered. Individual items on
this questionnaire assess the ability of households to meet the needs of
its members in terms of housing, health, energy, technology, prevention
and intellectual development; an overall score was derived by summing
across each item. The Home Observation for Measurement of the En-
vironment (HOME) Inventory, a semi-structured interview that mea-
sures quality and quantity of the caregiving environment, was ad-
ministered in a subset of participants at approximately the same time as
the visits for the neurobehavioral tests.
2.5. Data analysis
Univariate statistics, appropriate transformations, and graphical
displays were obtained for all variables before bivariate analyses.
Bivariate analysis of the data included Chi-square tests for categorical
variables and analysis of variance (ANOVA) to compare the continuous
outcomes or exposure within groups defined according to the dis-
tribution of each covariate. In initial fully adjusted linear regression
models, the outcomes demonstrated highly skewed residuals (with the
exception of CPT-II commission score and hit reaction time). Thus, to
address the skewness of the residuals, gamma regression was used to
examine the adjusted association between prenatal fluoride and each
neurobehavioral outcome instead of log transformation, which may
obscure model interpretation. In the gamma regression, we selected an
identity link, so that the interpretation for the regression coefficients is
the same as the linear regression (i.e., absolute difference in the mean
of the outcome per unit change in predictor). All statistical analyses
were performed in SAS software version 9.4. Covariates were selected a
priori based on their theoretical relevance or observed associations with
fluoride exposure, and/or the analyzed neurobehavioral outcomes. As
such, models were adjusted for the following maternal characteristics:
age at delivery (continuous, in years), years of education (continuous,
in years), marital status (married vs. others), and smoking history (ever-
smoker vs. non-smoker). Models were further adjusted for the following
child characteristics: gestational age at birth (continuous, in weeks),
age at neurobehavioral measurement (continuous, in years), sex (fe-
male vs. male), and birth order (first born vs. others), and socio-
economic status through a continuous measure based on reported
possessions and household assets (Thomas et al., 2016). Lastly, models
adjusted for potential cohort and Ca intervention effects through in-
clusion of a variable denoting from which study the participants ori-
ginated (cohort 2 - A, an observational cohort), cohort 3 subjects who
were randomized to the calcium supplement (cohort 3 - Ca+), and
cohort 3 subjects who were randomized to the placebo (cohort 3 -
Placebo) (Bashash et al., 2017).
Other potential confounders that were examined in sensitivity
analyses involving subsets of participants included the home environ-
ment (i.e. HOME score) (Thomas et al., 2016) assessed at the time of
outcome measurement, child contemporaneous fluoride exposure
measured by child urinary fluoride adjusted for specific gravity (CUFsg)
(Bashash et al., 2017), as well as maternal blood mercury and maternal
bone lead levels (a proxy for prenatal lead exposure to the fetus) given
that both are established neurodevelopmental toxicants (Bashash et al.,
2017). This was done through identifying and including the subset of
cases with data on each respective variable. In each subset, results were
then compared between the model adjusting for that variable and the
model not adjusting for that variable.
Model diagnostics were used to assess for violations of the model
assumptions and for identification of remaining influential observa-
tions. Cook's D identified three exposure observations as potentially
influential to the model results, and models were run with and without
these observations (Supplementary Fig. S1). Generalized additive
models (GAMs), estimated via cross validation in the R software, were
used to visualize the adjusted association between fluoride exposure
and measures of attention to examine potential non-linearity. Non-lin-
earity of the fluoride-outcome association was tested through the in-
clusion of a quadratic term in the model, and found to be significant in
four out of ten of the models (see Fig. 2 and Supplementary Fig. 1). We
applied the Benjamini–Hochberg false discovery rate (FDR) procedure
to address multiple testing corrections, using a false discovery rate of
Q=0.05 and m=10 tests to determine significance (Benjamini and
Hochberg, 1995).
3. Results
3.1. Population characteristics
Overall, 231 mothers with a minimum of one MUFcr and a matching
outcome (CRS-R or CPT-II) were identified for this project. However,
complete demographic and outcome information were missing among
17 mother-child pairs, leaving 214 participants for our analyses, of
whom 210 mother-child pairs had data for the CRS-R and CPT-II ana-
lyses (206 had data for both) (Fig. 1). Demographic information on
participants including data on exposure, outcomes, and key covariates
by cohort is shown in Table 1. Of the mothers included in our analysis,
154 (72%) were married at the time of recruitment, and 103 (48%) had
reported a history of ever smoking. Among the children, 147 (69%)
were not of firstborn status and 116 (54%) were female. Besides for
younger age of participants in cohorts 3 relative to cohort 2-, there were
no significant differences of maternal and children characteristics
across cohorts.
3.2. Exposure and outcome assessment
Of the 214 participants included in the study, 175 participants had
measurements of MUFcr from trimester 1, 80 from trimester 2, and 62
from trimester 3; 14 (6.5%) participants had all three measures, 78
(36.4%) had two measures, and 122 (57.0%) had one. The overall mean
level of MUFcr averaged across all the trimesters was 0.85mg/L, with
an Interquartile Range (IQR) of 0.46mg/L. There was no significant
difference of MUFcr across cohorts (Table 1A).
Overall, Mean ± SD scores across all of the CRS-R scales fell within
the average range (i.e. mean T=50 ± 10) (Table 1B). Around 10% of
participants fell in the clinically significant range (i.e. T-score≥ 70 on
the Index scores); specifically, clinically elevated scores were found
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among 22 (10.5%) children on the DSM-IV Hyperactivity-Impulsivity
scale, 18 (8.6%) children on the DSM-IV ADHD Total scale, and 17
(8.1%) children on the DSM-IV Inattention scale.
Mean ± SD for CPT-II scores for Omission Errors (55.53 ± 13.67),
Commission Errors (49.93 ± 9.22), and Hit Reaction Time
(52.51 ± 10.53) also fell within the average range (Table 1B).
3.3. Models of neurobehavioral outcomes
MUFcr was significantly associated with measures of the CRS-R in
the adjusted model (Table 2). Higher concentrations of MUFcr were
associated with a higher likelihood of parent-endorsed symptoms on the
following scales: DSM-IV Inattention, DSM-IV Total ADHD, Cognitive
Problem/Inattention, and the ADHD Index. On average, a 0.5 mg/L
higher MUFcr corresponded with a 2.84 (p < 0.01) higher score on the
DSM-IV Inattention Index; 2.38 (p= 0.02) higher score on the DSM-IV
Total ADHD Index; a 2.54 (p= 0.02) higher score on the Cognitive
Problem/Inattention Index; and 2.47 (p= 0.02) higher score on the
ADHD index. The associations between MUFcr and CRS-R scales re-
mained significant after correction for the multiple testing. As shown in
Fig. 2, a subset of the CRS-R outcomes exhibit a non-linear association
with the relationship between MUFcr and behavioral outcomes in-
creasing at first, followed by a plateau. There were no significant as-
sociations between MUFcr and any of the outcomes on the CPT-II
(Table 2; and Supplementary Fig. S2).
3.4. Sensitivity analyses
Sensitivity analyses on adjusted models for the study population
subset that also had HOME scores, CUFsg (there was no correlation
between MUFcr and CUFsg), maternal lead and mercury exposures did
not appreciably change the results for the CRS-R scores (Supplementary
Table 1). There was no significant interaction between sex and MUFcr
when we added an interaction term to the models.
4. Discussion
The current study aimed to characterize the longitudinal association
between prenatal fluoride exposure and symptoms of ADHD in offspring
as measured by parent-ratings on the CRS-R and a computerized test of
sustained attention and inhibitory control (CPT-II). In our cohort, higher
prenatal fluoride exposure, as measured by MUFcr, corresponded to more
ADHD-like symptoms on the CRS-R, particularly related to inattention as
indicated by the strong association with the following two scales:
Cognitive Problem/Inattention, and DSM-IV Inattention. In contrast,
MUFcr during pregnancy did not predict child performance on any of the
hyperactivity measures (i.e. Restless-Impulsive; Hyperactivity; DSM-IV
Hyperactivity-Impulsivity) nor the CPT-II outcomes.
In general, a 0.5 mg/L higher MUFcr (approximately the IQR) cor-
responded to higher scores on the CRS-R for DSM-IV Inattention (2.84
points) and Cognitive Problems and Inattention (2.54 points).
Consistency in these results across both of these outcome measures
strengthens the conclusion that inattention appears to be associated
with prenatal exposure to fluoride. These two scales contribute to the
global ADHD Index and the DSM-IV Total scores, which were also as-
sociated with higher levels of prenatal fluoride exposure; a 0.5 mg/L
increase in MUFcr corresponded to a 2.38 higher point score on the
DSM-IV ADHD Total Index and a 2.47 higher point score on the ADHD
Fig. 1. Flowchart describing source of mother–offspring subject pairs, fluoride and cognition study. Cohort 2A was designed as an observational birth cohort from
1997 to 2001. Cohort 3 was designed as a randomized double-blind placebo-controlled trial of calcium supplements, with mothers recruited early during pregnancy
from 2001 to 2006. “Ca” denotes subjects who were randomized to the calcium supplement; “placebo” denotes subjects who were randomized to the placebo. CRS-R
denotes Conners' Rating Scale – Revised and CPTII is Conners' Continuous Performance Test.
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Table 1
Cohort characteristics including key covariates, urinary fluoride levels, and outcome measurements. Statistical differences across the cohorts are reported upon in the
final column.
Cohort * N Mean (95% CI) % p
A) PARTICIPANTS
Child Sex (Girl) 2 A 37 52.90% .831
3 Ca 43 53.10%
3 Placebo 36 57.10%
Total 116 54.00%
First Child 2 A 24 34.30% .839
3 Ca 25 30.90%
3 Placebo 18 28.60%
Total 67 31.00%
Birth Weight (Kg) 2 A 70 3.05 (2.94, 3.16) .103
3 Ca 81 3.20 (3.10, 3.30)
3 Placebo 63 3.11 (3.01, 3.21)
Total 214 3.13 (3.07, 3.18)
Gestational Age (Weeks) 2 A 70 38.60 (38.21, 38.99) .647
3 Ca 81 38.74 (38.46, 39.02)
3 Placebo 63 38.49 (38.01, 38.97)
Total 214 38.62 (38.41, 38.84)
Age At Outcome Assessment (Year) 2 A 70 10.04 (9.89, 10.21) <.01
3 Ca 81 7.63 (7.52, 7.75)
3 Placebo 63 7.57 (7.44, 7.69)
Total 214 8.40 (8.23, 8.57)
Marital Status (Married) 2 A 46 65.70% .428
3 Ca 60 74.10%
3 Placebo 48 76.20%
Total 154 72.00%
Maternal Smoking (Ever Smoked) 2 A 32 46.40% .726
3 Ca 42 51.90%
3 Placebo 29 45.70%
Total 103 48.10%
Maternal Education (Years) 2 A 70 10.73 (10.08, 11.37) .580
3 Ca 81 11.11 (10.47, 11.75)
3 Placebo 63 10.68 (10.03, 11.34)
Total 214 10.86 (10.49, 11.23)
SES1 2 A 70 6.69 (6.10, 7.27) .604
3 Ca 81 6.32 (5.82, 6.82)
3 Placebo 63 6.33 (5.64, 7.02)
Total 214 6.44 (6.11, 6.78)
B) EXPOSURE AND OUTCOMES
MUFcr 2 2 A 70 0.87 (0.80, 0.95) 0.889
3 Ca 81 0.85 (0.78, 0.92)
3 Placebo 63 0.85 (0.76, 0.95)
Total 214 0.85 (0.81, 0.90)
CRS-R 3
Cognitive Problems + Inattention 2 A 68 55.16 (52.45, 57.87) .884
3 Ca 79 54.32 (51.85, 56.78)
3 Placebo 63 54.43 (51.78, 57.08)
Total 210 54.62 (53.14, 56.10)
Restless-Impulsive 2 A 68 55.43 (52.56,58.30) .490
3 Ca 79 55.19 (52.32, 58.07)
3 Placebo 63 54.28 (52.11, 56.45)
Total 210 54.35 (52.94, 55.75)
Hyperactivity 2 A 68 56.67 (53.62, 56.35) .217
3 Ca 79 54.52 (52.42, 56.62)
3 Placebo 63 53.70 (51.74, 55.66)
Total 210 54.97 (53.59, 56.35)
ADHD 4 Index 2 A 68 54.53 (51.77, 56.29) .865
3 Ca 79 54.56 (52.29, 56.82)
3 Placebo 63 53.70 (51.25, 56.14)
Total 210 54.30 (52.88, 55.71)
DSM-IV 5 Inattention 2 A 68 54.42 (51.60, 57.23) .825
3 Ca 79 53.92 (51.65, 56.22)
3 Placebo 63 53.29 (50.98, 55.60)
Total 210 53.89 (52.48, 55.30)
DSM-IV Hyperactivity-Impulsivity 2 A 68 57.54 (54.77, 60.32) .685
3 Ca 79 56.80 (54.59, 59.01)
3 Placebo 63 56.00 (53.76, 58.24)
Total 210 56.80 (55.42, 58.18)
DSM-IV ADHD Total 2 A 68 56.35 (53.72, 58.99) .670
3 Ca 79 55.63 (53.46, 57.81)
3 Placebo 63 54.79 (52.47, 57.12)
Total 210 55.61 (54.26, 56.97)
CPT-II 6
(continued on next page)
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Index. Our observed association of MUFcr and CRS-R seems to demon-
strate a ceiling effect, suggesting that higher levels of urinary fluoride
concentration did not substantially increase risk of ADHD-like symp-
toms.
Overall, our results are consistent with the ecological study by Malin
and Till (2015). Their cross-sectional study used national health surveys
conducted by the Centers for Disease Control and Prevention to esti-
mate the prevalence of ADHD and water fluoridation for each state.
Their findings showed that, after controlling for household income,
states in which a greater proportion of people received community
water fluoridation in 1992 tended to have a greater proportion of
children and adolescents who received an ADHD diagnosis in 2003,
2007, and 2011. The prevalence of ADHD increased from 7.8% in 2003
to 11% in 2011. A distinction between this U.S. study and the current
study is that our study was a longitudinal birth cohort with individual
biomarkers of fluoride exposure obtained during pregnancy when the
developing brain is thought to be at the highest risk for fluoride neu-
rotoxicity (Bashash et al., 2017). Moreover, the current study controlled
for relevant confounders that may be associated with ADHD, including
smoking, maternal education, child sex, HOME score, and exposure to
other contaminants. Further, our measure for ADHD was not physician-
diagnosed but rather approximated through validated questionnaires
and performance-based tests. Both studies examined populations that
are exposed to “optimal” levels of fluoride either through water or salt
fluoridation schemes. The exposure level in the Mexico City cohort is
generally lower than the populations living in endemic fluorosis areas
studied in China (Choi et al., 2012) where natural levels of fluoride are
often higher (> 2mg/L) than recommended levels for North American
(0.7mg/L). The mean concentration of MUF in our study is in the range
of the Canadian cohort (in review), and a New Zealand cohort of 59
pregnant women (median MUF=0.82mg/L) (Skeaff and Te Morenga,
2017).
Our finding of an association between MUFcr and symptoms of in-
attention are consistent with the growing body of evidence showing
dose-response relationships between early-life exposure to fluoride and
attention outcomes. Animal studies (Mullenix et al., 1995) reported
fewer behavioral initiations and less time exhibiting exploration be-
haviors among male and female rats exposed to 100 or 125 ppm
fluoride as weanlings (21 days postnatal) and among male rats whose
mothers were injected with 0.13mg/L of sodium fluoride on gestational
days 17–19. These particular behavioral effects are suggestive of hy-
poactivity. In human studies, high exposure to fluoride, as reflected by
the presence of moderate to severe dental fluorosis in primary teeth of
children living in southern Sichuan, China, was associated with poor
working memory, but not with other cognitive domains that were as-
sessed (Choi et al., 2015). Working memory is linked with the ability to
control attention and it is common for youth with ADHD to have
weaknesses in working memory (Kasper et al., 2012). A possible ex-
planation for the specific effect on inattention (Dugbartey, 1998) is that
fluoride exposure is contributing to thyroid hormone insufficiency.
Recent studies demonstrate that even relatively subtle changes in cir-
culating levels of TH in pregnancy (i.e. subclinical hypothyroidism) can
have adverse outcomes, including preterm birth, lowered IQ (Hollowell
et al., 1999; Murphy et al., 2015; Stagnaro-Green and Rovet, 2016;
Thompson et al., 2018) (Yang et al., 2008) and increased risk for at-
tention disorders (Modesto et al., 2015; Pakkila et al., 2014) (Rovet and
Hepworth, 2001). Some (Swarup et al., 1998) (Swarup et al., 1998), but
not all (Mcpherson et al., 2018), animal studies showed reductions in
T3 and T4 levels from fluoride exposure, even at low doses. Several
human studies have shown that elevated levels of fluoride in drinking
water predict higher TSH and lower T3 levels (Bachinskii et al., 1985;
Kheradpisheh et al., 2018; Singh et al., 2014), especially among chil-
dren (Yasmin et al., 2013), as well as an increased likelihood for a di-
agnosis of hypothyroidism. However, further research is needed to
examine how exposure to fluoride may affect thyroid function in
pregnancy. Another potential mechanism through which fluoride may
contribute to ADHD relates to the dopamine system. Animal studies
have shown that fluoride exposure can alter the levels of dopamine (Pal
and Sarkar, 2014). Dopamine is an important modulatory
Table 1 (continued)
Cohort * N Mean (95% CI) % p
Omission Errors 2 A 67 51.76 (48.49, 55.03) .024
3 Ca 80 57.56 (54.25, 60.87)
3 Placebo 63 56.80 (53.89, 59.70)
Total 210 55. 48 (53.62, 57.34)
Commission Errors 2 A 67 46.99 (44.43, 49.55) .007
3 Ca 80 51.18 (49.17, 53.20)
3 Placebo 63 51.37 (49.59, 53.16)
Total 210 49.90 (48.65, 51.15)
Hit Reaction Time 2 A 67 49.43 (47.00, 51.86) .016
3 Ca 80 53.77 (51.35, 56.18)
3 Placebo 63 54.05 (51.49, 56.60)
Total 210 52.46 (51.03, 53.90)
*Cohort: 2 A; ELEMENT Cohort 2A, an observational birth cohort from 1997 to 2001. 3 Ca and 3 Placebo, ELEMENT Cohort 3, a randomized double-blind placebo-
controlled trial of calcium supplements from 2001 to 2006. “Ca” denotes subjects who were randomized to the calcium supplement; “placebo” denotes subjects who
were randomized to the placebo. 1) SES, socioeconomic status; 2) MUFcr, Creatinine adjusted maternal urinary fluoride; 3) CRS-R, Conners’ Rating Scale – Revised;
CPT-II; 4) ADHD, Attention Deficit Hyperactivity Disorder; 5) DSM-IV, Diagnostic and Statistical Manual of Mental Disorders – Fourth Edition; 6) CPT-II, Conners’
Continuous Performance Test – Second Edition.
Table 2
Multivariatea gamma regression models of differences across CRS-R and CPT-II
scores per 0.5mg/L higher maternal creatinine-adjusted urinary fluoride
(MUFcr).
β 95% CI p
CRS-R scores (N=210)
Cognitive Problems+ Inattention 2.54 0.44 4.63 .0178
Restless-Impulsive 1.92 −0.07 3.91 0.0586
Hyperactivity 1.05 −0.91 3.00 0.2953
ADHD Index 2.47 0.43 4.50 0.0175
DSM-IV Inattention 2.84 0.84 4.84 0.0054
DSM-IV Hyperactivity-Impulsivity 1.69 −0.33 3.70 0.1016
DSM-IV ADHD Total 2.38 0.42 4.34 0.0176
CPT-II scores (N= 210)
Omission Errors 0.22 −2.30 2.74 0.8643
Commission Errors −0.43 −2.38 1.51 0.6641
Hit Reaction Time 1.07 −1.19 3.32 0.3546
a Adjusted for gestational age, birth weight, sex, parity (being the first child),
age at outcome measurement, and maternal characteristics including smoking
history (ever smoked vs. non-smoker), marital status (married vs. others),
education, socioeconomic status and cohort (Cohort 3 - Ca, Cohort 3 - placebo
and Cohort 2A).
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neurotransmitter in planning and initiation of motor responses, acti-
vation, switching, reaction to novelty and processing of reward
(Faraone et al., 2015).
The stronger association between prenatal fluoride exposure and
parent-reports of attention problems may be explained by the CRS-R
measuring distinct and more extensive constructs that rely on attention
(e.g. new learning, ability to hold information and complete tasks, or-
ganizational skills, etc.) than those assessed by the CPT-II. Additionally,
it has been shown that CPT-II performance and parent rating scales are
moderately correlated at best (Gualtieri and Johnson, 2005), suggesting
that these measures are assessing different constructs. Other studies
examining prenatal Polychlorinated Biphenyis (PCBs) exposure and
sustained attention (Vreugdenhil et al., 2004) that report using the
computerized continuous performance test with children aged 4 and
11 years also fail to show an association with this measure, but do find
an association using other psychometric tests of attention (e.g. digit
cancellation task). Further investigation of cognitive performance on
other domains, such as learning and memory, is warranted in our study
cohort.
Key strengths of this study include the relatively large pregnancy
cohort that has a biorepository with a capacity to capture high quality
individual biomarker exposure across multiple developmental time
points, longitudinal follow-up, detailed assessment of ADHD-like be-
haviors using both rating scales and performance based measures, as
well as measurement of additional health outcomes and potential
covariates using validated techniques (Thomas et al., 2016). Assess-
ment of attention, hyperactivity, and impulsivity using multiple mea-
sures allowed us to examine different types of ADHD-like behaviors
using continuous scales that are sensitive to both clinical and sub-
clinical symptoms of ADHD. This approach minimizes the limitations of
viewing ADHD as a categorical and conceptually distinct disorder.
Our study also has some limitations. The cohort was not initially
designed to study fluoride exposure and so we are missing some aspects
of fluoride exposure assessments (e.g., detailed assessments of diet,
water, etc.) that are now underway. The urinary samples were not
available for all trimesters of pregnancy for majority of the participants;
in particular, for those with only one sample, we cannot rule out the
possibility that some samples may reflect acute exposure. Differences in
the proportion of fluoride that is excreted in the urine have been de-
scribed for different age groups as well as for pregnant women. Data on
the percentage of fluoride excreted for children and adults are avail-
able, which makes estimation of intake feasible. On the other hand,
data for pregnant women are sparse, making estimates of intake from
urinary concentration not feasible. Therefore, while urinary fluoride is
a valid biomarker to identify differences in exposure levels in pregnant
women, it is not possible, with the currently available data, to estimate
how concentration levels relate to intake. With regards to our outcome
measure, we did not have information on family history or genetic
markers associated with ADHD, nor were children assessed clinically
for a diagnosis of ADHD. Only parent reports were used for the CRS-R,
and not teacher reports. This is a limitation to our study as previous
studies have shown that there can be considerable variation between
the two sources in terms of identifying ADHD-associated behaviors
(Lavigne et al., 2012). Nevertheless, parents were unaware of their
offspring's fluoride exposure status, removing reporting bias as a lim-
itation. Although elevated scores on behavioral checklists like the CRS-
R may be associated with a diagnosis of ADHD, the functional con-
sequences of the symptoms must also be characterized for clinically
diagnosing the disorder.
Fig. 2. Association of maternal creatinine-adjusted urinary fluoride (MUFcr) and Conners' Parent Rating Scales-Revised (CRS-R) measures in children at age 6 to
12 years.
Outcome data are adjusted for gestational age, birth weight, sex, parity (being the first child), age at outcome measurement, and maternal characteristics including
smoking history (ever smoked vs. non-smoker), marital status (married vs. others), education, socioeconomic status and cohort (Cohort 3 Ca, Cohort 3 placebo and
Cohort 2A). Shaded area is the 95% confidence interval. The short vertical bars on the x-axis reflect the density of urinary fluoride measures. Individual data points
are individual observations, n=210.
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5. Conclusion
In summary, we observed a positive association between higher
prenatal fluoride exposure and more behavioral symptoms of inatten-
tion, but not hyperactivity or impulse control, in a large Mexican cohort
of children aged 6 to 12 years. The current findings provide further
evidence suggesting neurotoxicity of early-life exposure to fluoride.
Replication of these findings is warranted in other population-based
studies employing biomarkers of prenatal and postnatal exposure to
fluoride.
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